La neonatologia ha estat reconeguda com àrea de capacitació específica de la pediatria.

Editorial del vol. 75 núm. 1 de la publicacióLa formació en neonatologia està ben organitzada a Austràlia, els Estats Units i el Canadà. A Europa, l’European Board of Pediatrics (EBP) va reconèixer el 1997 el Working Group in Neonatology (WGN) de l’European Society for Pediatric Research (ESPR). A l’agost del 2001, el WGN-ESPR es va convertir en l’European Society for Neonatology (ESN), reconeguda per la Confederation of European Societies in Pediatrics (CESP) com l’organització representativa de tots els neonatòlegs europeus 1. L’ESN ha elaborat un programa de formació per als neonatòlegs a Europa amb l’objectiu d’harmonitzar els programes de formació entre els diferents països europeus i establir uns graus de coneixement i habilitats clarament definits 2, la qual cosa permetria l’intercanvi de neonatòlegs entre els països europeus participants

Valoración del Screening metabólico neonatal

Importáncia de las enfermedades metabólicas consideradas como grup. El capítulo de los errores innatos del metabolismo se incrementa progresivamente a medida que se profundiza en su estudio y técnicas diagnósticas. Son más de 250 las entidades descritas (1 ), la mayo ria de las cuales se presentan..

Growth of preterm infants at the time of global obesity

Preterm birth, 90% of which occurs between 32 and <37 weeks' gestation,1 2 is a complex heterogeneous syndrome interlinked with the stillbirth and intrauterine growth restriction syndromes. Its phenotypes are associated with different gains in neonatal weight, morbidity and mortality, and perhaps body composition, growth and development. Preterm birth is related to several aetiologies, although nearly 30% of all preterm births are not associated with any maternal/pregnancy conditions or fetal growth restriction

Trends in survival among extremely-low-birth-weight infants (less than 1000 g)without significant bronchopulmonary dysplasia

Objective The aim of this study was to analyze the evolution from 1997 to 2009 of survival without significant (moderate and severe) bronchopulmonary dysplasia (SWsBPD) in extremely-low-birth-weight (ELBW) infants and to determine the influence of changes in resuscitation, nutrition and mechanical ventilation on the survival rate. Study design In this study, 415 premature infants with birth weights below 1000 g (ELBW) were divided into three chronological subgroups: 1997 to 2000 (n = 65), 2001 to 2005 (n = 178) and 2006 to 2009 (n = 172). Between 1997 and 2000, respiratory resuscitation in the delivery room was performed via a bag and mask (Ambu®, Ballerup, Sweden) with 40-50% oxygen. If this procedure was not effective, oral endotracheal intubation was always performed. Pulse oximetry was never used. Starting on January 1, 2001, a change in the delivery room respiratory policy was established for ELBW infants. Oxygenation and heart rate were monitored using a pulse oximeter (Nellcor®) attached to the newborn"s right hand. If resuscitation was required, ventilation was performed using a face mask, and intermittent positive pressure was controlled via a ventilator (Babylog2, Drägger). In 2001, a policy of aggressive nutrition was also initiated with the early provision of parenteral amino acids. We used standardized parenteral nutrition to feed ELBW infants during the first 1224 hours of life. Lipids were given on the first day. The glucose concentration administered was increased by 1 mg/kg/minute each day until levels reached 8 mg/kg/minute. Enteral nutrition was started with trophic feeding of milk. In 2006, volume guarantee treatment was instituted and administered together with synchronized intermittent mandatory ventilation (SIMV + VG). The complications of prematurity were treated similarly throughout the study period. Patent ductus arteriosus was only treated when hemodynamically significant. Surgical closure of the patent ductus arteriosus was performed when two courses of indomethacin or ibuprofen were not sufficient to close it. Mild BPD were defined by a supplemental oxygen requirement at 28 days of life and moderate BPD if breathing room air or a need for <30% oxygen at 36 weeks postmenstrual age or discharge from the NICU, whichever came first. Severe BPD was defined by a supplemental oxygen requirement at 28 days of life and a need for greater than or equal to 30% oxygen use and/or positive pressure support (IPPV or nCPAP) at 36 weeks postmenstrual age or discharge, whichever came first. Moderate and severe BPD have been considered together as"significant BPD". The goal of pulse oximetry was to maintain a hemoglobin saturation of between 88% and 93%. Patients were considered to not need oxygen supplementation when it could be permanently withdrawn....

Effectiveness of a probiotic combination on the neurodevelopment of the very premature infant

Probiotics have shown a benefit in reducing necrotising enterocolitis in the premature infant, however the study of their effect on premature neonates' neurodevelopment is limited. The aim of our study was to elucidate whether the effect of Bifidobacterium bifidum NCDO 2203 combined with Lactobacillus acidophilus NCDO 1748 could positively impact the neurodevelopment of the preterm neonates. Quasi-experimental comparative study with a combined treatment of probiotics in premature infants < 32 weeks and < 1500 g birth weight, cared for at a level III neonatal unit. The probiotic combination was administered orally to neonates surviving beyond 7 days of life, until 34 weeks postmenstrual age or discharge. Globally, neurodevelopment was evaluated at 24 months corrected age. A total of 233 neonates were recruited, 109 in the probiotic group and 124 in the non-probiotic group. In those neonates receiving probiotics, there was a significant reduction in neurodevelopment impairment at 2 years of age RR 0.30 [0.16-0.58], and a reduction in the degree of impairment (normal-mild vs moderate-severe, RR 0.22 [0.07-0.73]). Additionally, there was a significant reduction in late-onset sepsis (RR 0.45 [0.21-0.99]). The prophylactic use of this probiotic combination contributed to improving neurodevelopmental outcome and reduced sepsis in neonates born at < 32 weeks and < 1500 g

Recomendaciones para la informatización de los servicios de neonatología

El objetivo es proporcionar el marco para la recopilación de datos en el área de la salud de los recién nacidos que permitan la armonización de la asistencia sea cual sea su lugar de nacimiento. Para ello es necesario conocer la población atendida y la mayor dificultad es la ausencia de un sistema de recopilación de datos y de unos estándares asistenciales para todas las condiciones del recién nacido. Es imprescindible disponer de un registro único en el que se recojan los principales datos perinatales y neonatales de todos los recién nacidos. La Sociedad Española de Neonatología (SEN) debe ser el depositario y responsable de la base de datos, que debe cumplir todas las exigencias legales de privacidad y confidencialidad. A nivel de cada centro es posible conocer el peso relativo de la afección atendida por grupos de diagnósticos relacionados (DRG) y los resultados desde el aspecto de calidad asistencial. Mediante análisis comparativos (estudios de benchmarking,. . .) es posible establecer las pautas de diagnóstico y tratamiento. Es necesario conocer la población de recién nacidos atendida y definir criterios de diagnóstico y tratamiento para mejorar la calidad asistencial. La SEN desea dirigirse a los responsables asistenciales de los centros hospitalarios para pedirles su apoyo y colaboración en la puesta en marcha de estas recomendaciones

Impact of chorioamnionitis on exhaled nitric oxide and endotracheal aspirate levels of nitrites-nitrates and interleukin-8 in mechanically ventilated preterm neonates.

OBJECTIVES: To assess the influence of maternal chorioamnionitis on early exhaled nitric oxide (NO) and levels of nitrites-nitrates and interleukin (IL)-8 in endotracheal aspirate fluid in mechanically ventilated preterm neonates. STUDY DESIGN: Cross-sectional study. PATIENT-SUBJECT SELECTION: Between September 2007 and August 2009, 54 mechanically ventilated preterm neonates were included. Patients were divided into two groups according to the presence or absence of maternal chorioamnionitis, and those without chorioamnionitis (controls) were further stratified into two subgroups by birth weight < or ≥ 2,000 g. METHODOLOGY: The ventilator used was a Babylog 8000. The NO level assessed was the plateau value given by the software of the Sievers NOA apparatus. Collection of endotracheal aspirate fluid samples was performed coinciding with routine aspirations and using the dry technique. RESULTS: The two groups of control neonates showed statistically significant differences in exhaled NO expressed as nl/min and normalized exhaled NO expressed as either nl/min or nl/min/kg, so they are not homogeneous and cannot be used in clinical practice. Serum C-reactive protein and endotracheal aspirate levels of nitrites-nitrates were significantly higher in the chorioamnionitis group than in controls (3.6 vs. 1.07 µmol/L; P = 0.035). Nitrites-nitrates levels were positively correlated with exhaled NO in ppb (ρ = 0.367; P = 0.006). Minute exhaled endogenous NO was significantly higher in the chorioamnionitis group (0.48 vs. 0.27 nl/min/kg; P = 0.021). CONCLUSIONS: In mechanically ventilated preterm infants weighing <2,000 g, maternal chorioamnionitis was associated with an increase of early exhaled NO (nl/min/kg) and serum levels of C-reactive protein and levels of nitrites-nitrates in endotracheal aspirate fluid

Influence of in-home nursing care on the weight of the early discharged preterm newborn

Introducción: la atención domiciliaria de enfermería (ADE) del recién nacido prematuro próximo al alta en su propio domicilio en lugar del hospital normaliza la situación familiar, favorece la lactancia materna y el desarrollo del recién nacido y permite la reorganización de los recursos sanitarios. El propósito del presente trabajo es demostrar que el prematuro sometido al programa de ADE experimenta un aumento de peso superior en el domicilio respecto al hospital y no incrementa su morbilidad. Pacientes y metodología: estudio comparativo de 65 casos y 65 controles (apareados por peso, edad y sexo), prematuros, de procedencia interna y con peso al alta inferior a 2.100 g. La ADE fue administrada por un pediatra neonatólogo y 2 enfermeras especializadas en neonatología dependientes de los servicios hospitalarios, que realizaron visitas seriadas a domicilio. El aumento de peso se calculó por g/día y g/kg/día, comparando la semana previa al inicio del estudio con la primera semana del estudio. Resultados: los grupos fueron comparables. El aumento de peso en el grupo con ADE fue de 38 g/día, significativamente superior al del grupo control (31 g/día). Las variables independientes predictoras del «aumento en g/kg/día durante el estudio» fueron la ADE, el sexo varón, tomar menos lactancia materna y no haber padecido una hemorragia peri-intraventricular. La morbilidad neonatal fue similar. Conclusiones : la ADE implicó un mayor aumento de peso del recién nacido en casa que durante su permanencia en el hospital, y no aumentó la morbilidad neonatal

Outbreak caused by Escherichia coli O18:K1:H7 sequence type 95 in a neonatal intensive care unit in Barcelona, Spain.

Background: Escherichia coli is one of the most frequent causes of late-onset neonatal sepsis. The aim of this study was to characterize an outbreak of neonatal sepsis occurring in the neonatal intensive care unit (NICU) of the Hospital Clinic of Barcelona from April to August 2013. Methods: After presentation of the index case, all E. coli isolates from previously hospitalized neonates, health care workers, and neonates admitted to the NICU from April to October 2013 were tested for K1 antigen positivity and epidemiologically compared by pulse-field gel electrophoresis. Furthermore, the E. coli K1 strains collected from neonates during this period were analyzed by different methods (serotyping, phylotyping, PCR of virulence factors, antimicrobial resistance, and 'in vitro' assays in HMBEC). Results: An E. coli O18:K1:H7 sequence type 95 and phylogenetical group B2 strain was the cause of the outbreak involving 6 preterm neonates: one with late septicemia due to a urinary focus and 5 with late-onset septicemia and meningitis, 3 of whom died. All showed the same pulsotype, full resistance to ampicillin and intermediate resistance to gentamicin. The outbreak strain carried the PAI IIJ96-like domain that could explain the high-grade bacteremia necessary to develop meningitis. Conclusions: All the E. coli isolates responsible for this outbreak belonged to a single clone suggesting a common source of infection, and it was categorized as O18:K1:H7. Despite the bacteria's pathogenicity has an important role in the severity of infection, the host-associated factors were crucial for the fatal outcomes

PRL-3 is essentially overexpressed in primary colorectal tumours and associates with tumour aggressiveness

Phosphatase PRL-3 has been involved in different types of cancer, especially in metastases from colorectal carcinoma (CRC). In this study, we explored both isoforms of PRL-3 as a biomarker to predict the recurrence of stage IIIB-C CRC. Overexpression of PRL-3 was investigated in primary human colorectal tumours (n=20) and hepatic metastases (n=36) xenografted in nude mice, samples characterised by absence of human non-tumoral cells, showing a high degree of expression in metastases (P=0.001). In 27 cases of matched normal colonic mucosa/primary tumour/hepatic metastases, PRL-3 overexpression occurs in primary tumours vs normal mucosa (P=0.001) and in hepatic metastases vs primary tumours (P=0.045). Besides, our results in a series of 80 stage IIIB-C CRC primary tumours showed that high levels of PRL-3 were an independent predictor of metastasis (P<0.0001; OR: 9.791) in multivariate analysis of a binary logistic regression and that PRL-3 expression tightly correlates with parameters of bad outcome. Moreover, PRL-3 expression associated with poor outcome in univariate (P<0.0001) and multivariate Cox models (hazard ratio: 3.322, 95%, confidence interval: 1.405-7.852, P=0.006). In conclusion, PRL-3 is a good marker of aggressiveness of locally advanced CRS and a promising predictor of distant metastases. Nevertheless, for prognosis purposes, it is imperative to validate the cutoff value of PRL-3 expression in a larger and consecutive series and adjuvant setting